Search

Search Constraints

You searched for: Author/Creator Salas, Maria Queralt

Search Results

1. Effect of pre‐transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis. (27th July 2021)

2. High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis. Issue 13 (9th November 2020)

3. Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation. (6th October 2019)

4. Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infections. Issue 14 (6th December 2021)

5. Prolactin, a potential biomarker for chronic GVHD activity. (26th October 2020)

6. Prolactin, a potential biomarker for chronic GVHD activity. (26th October 2020)

7. Reduced intensity allogeneic stem cell transplant with anti‐thymocyte globulin and post‐transplant cyclophosphamide in acute myeloid leukemia. (9th September 2019)

8. Reduced‐intensity conditioning allogeneic transplant with dual T‐cell depletion in myelofibrosis. (30th September 2019)

10. The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting. Issue 4 (3rd March 2021)